Development of an Asthma Research Core Center

描述（由申请人提供）：哮喘是一种呼吸道慢性炎症性疾病，据世界卫生组织估计，全世界有1.5亿人患有哮喘，其全球药物治疗费用每年超过50亿美元。辛辛那提儿童医院医疗中心（CCHMC）在初级保健和专科诊所为近7000名哮喘儿童提供临床护理。去年，3000多名儿童在CCHMC急诊科接受治疗，初步诊断为急性哮喘加重，885名患者（29.5%）入院治疗急性哮喘加重。CCHMC投入了大量资源来促进哮喘研究，包括建立哮喘研究部，该部门与哮喘中心合作创建了一个全面的哮喘项目，现在为CCHMC的哮喘临床和研究活动提供了一个中心基地。患有哮喘的患者具有相似的临床症状，但该疾病在表型和自然史方面具有异质性3,4。这种异质性增加了研究和治疗哮喘的难度。哮喘的异质性尚不清楚，遗传和环境影响哮喘发展和哮喘疾病表达的机制在很大程度上是未知的。因此，提出的哮喘研究核心的中心目标是提高对哮喘异质性的理解。为了实现这一目标，我们提出了两个目标：目标1：招募或提升一名新的教师进入终身教职，以开展一个研究项目，重点研究与阐明哮喘异质性相关的机制。目标2：在哮喘研究领域开展一个试点研究项目，以支持在上述领域获得终身教职的新教员。

DESCRIPTION (provided by applicant): Asthma, a chronic inflammatory disorder of the airways, is estimated by the World Health Organization to affect 150 million people worldwide and its global pharmacotherapeutic costs exceed $5 billion per year. Cincinnati Children's Hospital Medical Center (CCHMC) provides clinical care to -7000 asthmatic children in the primary care and specialty clinics. Last year, over 3000 children were treated in the CCHMC Emergency Department with the primary diagnosis of an acute asthma exacerbation, and 885 patients (29.5%) were admitted to the hospital for management of acute asthma exacerbations. CCHMC has invested considerable resources to promote asthma research including the establishment of the Division of Asthma Research, which has partnered with the Asthma Center to create a comprehensive Asthma Program, which now provides a central base for the clinical and research activities for asthma at CCHMC. Patients suffering from asthma share similar clinical symptoms, but the disease is heterogenous in terms of phenotypes and natural history 3, 4. This heterogeneity contributes to the difficulty in both studying and treating asthma. The heterogeneity in asthma is poorly understood and the mechanisms by which genetic and environmental influences impact asthma development and asthma disease expression are largely unknown. As such, the proposed Asthma Research Core has the central goal of improving the understanding of the heterogeneity in asthma. In order to accomplish this goal, we propose 2 aims: Aim #1: To recruit or promote a new faculty member into the tenure track to develop a research program focused a topic relevant to elucidating the mechanisms contributing to asthma heterogeneity. Aim #2: To develop a pilot research program in Asthma Research to support new faculty in the tenure track in the areas outlined above. The frequency of absent or incomplete efficacy in asthma treatment is as high as 70%, due to the inherent heterogeneity in asthma phenotypes caused by multiple genetic and environmental influences. The central goal of this proposal is to improve the understanding of the heterogeneity in asthma. Improved understanding of asthma phenotypes will enable informed personalized treatment plans and likely will result in substantial reduction in asthma expenditures.